NB Medical Education’s Post

Don’t miss the latest 2024 ESC Guidelines on peripheral arterial and aortic diseases! Peripheral arterial and aortic diseases require a tailored and patient-centric approach. The new ESC 2024 recommendations provide evidence-based insights, highlighting the importance of a multidisciplinary strategy to enhance patient care. 🔬 By integrating the latest research into clinical practice, these guidelines aim to significantly improve patient outcomes and quality of life. 📚 Discover how these guidelines are redefining vascular disease management 👉 https://lnkd.in/e5_3Wkgx #Healthcare #Cardiology #ESC2024 #Medicine #Innovation #PatientCare #Guidelines

The American Heart Association and American College of Cardiology Joint Committee have released a report on the 2024 clinical performance and quality measures for adults with valvular and structural cardiovascular disease. Healthcare professionals can visit the link to review the report published in the peer-reviewed journal, Circulation: Cardiovascular Quality and Outcomes: https://lnkd.in/d_x_wBhn #CardiovascularCare #HeartHealth #ValvularDisease #StructuralHeartDisease #ClinicalPerformance #QualityMeasures #MedicalResearch #HealthcareQuality

Nowadays, partly due to the rising prevalence of obesity and diabetes, vascular diseases are increasingly common in many countries around the world. The most common vascular diseases include peripheral artery disease (PAD), carotid artery disease, and aortic aneurysm disease. Aortic aneurysm ranks globally among the top 10 causes of cardiovascular deaths and is a leading cause of mortality from large vessel diseases. Canon Medical, together with our partners, strives to bring together experts in the field to share discoveries and insights from research and clinical practice. The Canon Vascular Days consist of daily webinars (starting at 7 pm CEST for 1h) led by subject matter experts from across the globe. These sessions will provide a platform for professional education as we discuss state-of-the-art imaging and clinical management using illustrative clinical examples. Register now to secure your spot for the Vascular Days, made possible by the Canon Medical Academy! Register at https://lnkd.in/gyeJbcV5 #MadePossible #MadeForLife #Vascular

Test your knowledge of Right Heart Failure in the ED with this month's Clinical Case Challenge! For a patient with acute pulmonary embolism with right ventricular dysfunction, elevated right atrial pressure (≥15 mm Hg) by inferior vena cava ultrasound, and initially normal blood pressure, which would be the preferred approach to preload management? a. 250-mL bolus of crystalloid fluid b. 500-mL bolus of crystalloid fluid c. 1000-mL bolus of crystalloid fluid d. 40 to 80 mg IV furosemide See all your options and pick the best answer! Did you get it right? https://loom.ly/oWRmeC0

Delighted to work on this review discussing the role of Lipoprotein(a) reduction in cardiovascular disease published in the Journal of Clinical Medicine. Lipoprotein(a) is six times more atherogenic than LDL cholesterol on a per-particle basis, is largely genetically determined and a risk factor for coronary heart disease and aortic valve stenosis. There are currently no approved drugs for lipoprotein(a) reduction in clinical practice, but a number of clinical trials are ongoing. Pelacarsen is undergoing phase 3 clinical trials (Lp(a) HORIZON) with earlier trial data showing a dose-dependent reduction in lipoprotein(a) between 35-80%.

What is Cardiology Diagnostic Testing? 🩺 Cardiology diagnostic testing refers to a variety of specialized tests designed to evaluate the structure and function of your heart and blood vessels. These tests help identify issues that may be affecting your cardiovascular health, including blockages, valve problems, or irregular heart rhythms. At Desert Cardiovascular Consultants, we use advanced diagnostic tools to uncover the root of your symptoms, so you can receive the most effective treatment. Your heart delivers oxygen-rich blood to your entire body—protecting it is crucial to your overall health. Book your consultation today by calling (725) 726-3162 or visiting https://lnkd.in/enetVVRe to discuss the right diagnostic testing for you. ❤️ #HeartHealth #DiagnosticTesting #CardiovascularHealth #HeartDisease #HealthCheck #CardiovascularConsultants #HeartCare #PreventiveCare #CardiacTesting #HeartWellness #HeartHealthAwareness #Consultation #HealthCareProfessionals

A 40-year-old man presents to the clinic with worsening shortness of breath and a persistent dry cough for the past several months. He reports significant fatigue and mild chest discomfort, particularly on the left side. He denies fever, hemoptysis, or night sweats. His medical history is significant for Hodgkin's Disease, which was treated 15 years ago with chemotherapy and radiation therapy to the left hilar region. He has no history of smoking, and there is no family history of pulmonary disease. Physical examination: Vital signs: Temperature 98.6°F Blood pressure 125/80 mm Hg Pulse 95/min Respiratory rate 22/min Oxygen saturation 92% on room air Auscultation: Decreased breath sounds and a dull percussion note over the left hemithorax, with inspiratory crackles noted in the left lung base. No jugular venous distension or peripheral edema is observed. Laboratory findings include: Arterial Blood Gas (ABG) on room air: pH 7.43 PaCO2 37 mm Hg PaO2 68 mm Hg Complete Blood Count: Hemoglobin 14.0 g/dL White blood cell count 6,800/mm³ Pulmonary Function Tests: Reduced forced vital capacity (FVC) Reduced total lung capacity (TLC) Reduced diffusing capacity of the lungs for carbon monoxide (DLCO) A chest x-ray is attached. Which of the following is the most likely diagnosis? A) Radiation-Induced Pulmonary Fibrosis B) Idiopathic Pulmonary Fibrosis C) Pulmonary Embolism Please like, follow, share, repost, and comment if you like my content. I try my best to respond to every comment personally. If you want to see all of my future posts, hit the bell icon next to my profile.

An 87-year-old patient presents to the Emergency Department with dyspnea and desaturation without fever. Medical history includes multiple comorbidities, including severe COPD and chronic biventricular heart failure with cor pulmonale. Blood tests show neutrophilic leukocytosis, elevated C-reactive protein, and increased proBNP. Chest X-ray reveals bilateral pleural effusion, more pronounced on the right side. The case was initially assessed as heart failure secondary to a COPD exacerbation. Treatment with antibiotics and diuretics was started, and the patient was transferred to a subacute intermediate care setting. Upon my evaluation, the patient was dyspneic, requiring oxygen, afebrile, and hemodynamically stable. Thoracic POCUS showed hepatization of the right lower lobe with massive, loculated pleural effusion. I suspect a right basal pneumonia and pleural empyema. The patient was urgently referred back to ED for thoracentesis and further diagnostic workup. This is an interesting case illustrating how ultrasound can be superior to X-ray and comparable to CT in thoraco-pulmonary diagnostics. #POCUS #pointofcareultrasound #empyema

🔬 Spotlight on Rare Diseases: Arrhythmogenic Ventricular Cardiomyopathy (ARVC) 🔬 As an advanced heart failure and transplant cardiologist, I’ve encountered Arrhythmogenic Ventricular Cardiomyopathy (ARVC) in 3 to 4 patients annually. This might seem like a small number, but it highlights the reality of managing rare but serious cardiac conditions in specialized clinics. 💔 ARVC Prevalence: In the general population, ARVC affects approximately 0.02% to 0.04% of individuals. This translates to about 1 in 2,500 to 1 in 5,000 people. Despite its rarity, ARVC is a major cause of sudden cardiac death in young people and athletes. 🩺 Clinical Impact: The higher frequency of ARVC cases in my practice underscores the importance of specialized care for patients with complex cardiac conditions. Our clinic is dedicated to providing advanced diagnostics and tailored treatments to manage and mitigate the risks associated with ARVC. 🔗 Learn More: By raising awareness and fostering discussions on rare diseases like ARVC, we can improve early detection and intervention. Let’s continue to support research and patient care initiatives that make a difference in the lives of those affected by rare cardiac conditions. #Cardiology #HeartHealth #RareDiseases #ARVC #PatientCare #MedicalResearch #HeartFailure #TransplantCardiology

📢 "Age and Mortality in V-V ECMO: New Comprehensive Study" A recent groundbreaking study by Tommaso Tonetti et al., published in Critical Care, sheds new light on how age influences mortality in patients undergoing veno-venous extracorporeal membrane oxygenation (V-V ECMO) for acute respiratory distress syndrome (ARDS). As the use of ECMO has expanded in critical care settings, the role of age as an eligibility criterion has remained controversial, with different healthcare institutions adopting varying policies. This study addresses this crucial issue by conducting an extensive analysis of clinical data, aiming to clarify the relationship between age and mortality outcomes in ARDS patients treated with V-V ECMO. The researchers performed a systematic review and meta-regression of clinical studies published between 2015 and June 2024. To ensure robust findings, only studies involving at least six ARDS patients who were treated with V-V ECMO were included. The primary focus was on the relationship between patient age and mortality in the intensive care unit (ICU) and hospital settings. #ECMOTeam #ExtracorporealMembraneOxygenation #ECMOSupport #CriticalCareMedicine #CardiopulmonarySupport Perfusion Times advocates for content grounded in evidence-based medicine, drawing from prestigious academic journals open access peer-reviewed. hashtag #follow #PerfusionTimes